Update shared on 06 Dec 2025
Narrative Update on Clariane
Analysts have marginally increased their price target on Clariane to approximately €4.72, reflecting slightly stronger expectations for revenue growth and profit margins, while maintaining a broadly unchanged valuation framework.
What's in the News
- Clariane SE confirmed its group earnings guidance for 2025, reiterating confidence in its financial trajectory despite sector headwinds (company guidance).
- The company maintained its target for organic revenue growth of around 5 percent in 2025, signaling expectations of steady underlying demand across its care and services portfolio (company guidance).
Valuation Changes
- Fair Value: Unchanged at approximately €4.72 per share, indicating a stable central valuation estimate.
- Discount Rate: Held steady at 12.3 percent, implying no change to the assumed risk profile or cost of capital.
- Revenue Growth: Risen slightly from about 3.58 percent to around 3.68 percent, reflecting marginally stronger top line expectations.
- Net Profit Margin: Increased modestly from roughly 2.34 percent to about 2.37 percent, suggesting a small improvement in projected profitability.
- Future P/E: Fallen slightly from around 17.62x to approximately 17.42x, indicating a marginally lower multiple applied to future earnings.
Have other thoughts on Clariane?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.